Zhenqing Feng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhenqing Feng has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Jin Zhu
Huadong Medical Institute of Biotechniques
2 shared publicationsGuipeng Ding
Key Laboratory of Antibody Technique of Ministry of Health, Department of Pathology, Nanjing Medical University, Nanjing, 210029, China
1 shared publication- Jian-Ping Zhang
Department of General Surgery, the Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China
1 shared publication Kaikun Liu
1 shared publicationQi Tang
1 shared publicationShibing Liao
1 shared publication
Latest Publications
- Open Access
- 24 July 2013
- Published by Springer Nature in Cytotechnology
- Vol. 66 (3) , 395-411
A murine–human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro
The online version of this article (doi:10.1007/s10616-013-9587-x) contains supplementary material, which is available to authorized users.
- 24 July 2013
- Published by Springer Nature in Cytotechnology
- Vol. 66 (3) , 395-411
Open AccessA murine–human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro
The online version of this article (doi:10.1007/s10616-013-9587-x) contains supplementary material, which is available to authorized users.
- 1 October 2007
- Published by Spandidos Publications in Oncology Reports
- Vol. 18 (4) , 943-951
Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray
The genetic background of hepatocellular carcinoma (HCC) has yet to be completely understood. Here, we describe the application of suppression subtractive hybridization (SSH) coupled with cDNA microarray analysis for the isolation and identification of differential expression of genes in HCC. Twenty-six known genes were validated as up-regulated and 19 known genes as down-regulated in HCC. The known genes identified were found to have diverse functions. In addition to the overexpression of AFP, these genes (increased in the presence of HCC) are involved in many processes, such as transcription and protein biosynthesis (HNRPDL, PABPC1, POLR2K, SRP9, SNRPA, and six ribosomal protein genes including RPL8, RPL14, RPL41, RPS5, RPS17, RPS24), the metabolism of lipids and proteins (FADS 1, ApoA-H, ApoM, FTL), cell proliferation (Syndecan-2, and Annexin A2), and signal transduction (LRRC28 and FMR1). Additionally, a glutathione-binding protein involved in the detoxification of methylglyoxal known as GLO1 and an enzyme which increases the formation of prostaglandin E(2) known as PLA2G10 were up-regulated in HCC. Among the under-expressed genes discovered in HCC, most were responsible for liver-synthesized proteins (fibrinogen, complement species, amyloid, albumin, haptoglobin, hemopexin and orosomucoid).
- 1 October 2007
- Published by Spandidos Publications in Oncology Reports
- Vol. 18 (4) , 943-951
Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray
The genetic background of hepatocellular carcinoma (HCC) has yet to be completely understood. Here, we describe the application of suppression subtractive hybridization (SSH) coupled with cDNA microarray analysis for the isolation and identification of differential expression of genes in HCC. Twenty-six known genes were validated as up-regulated and 19 known genes as down-regulated in HCC. The known genes identified were found to have diverse functions. In addition to the overexpression of AFP, these genes (increased in the presence of HCC) are involved in many processes, such as transcription and protein biosynthesis (HNRPDL, PABPC1, POLR2K, SRP9, SNRPA, and six ribosomal protein genes including RPL8, RPL14, RPL41, RPS5, RPS17, RPS24), the metabolism of lipids and proteins (FADS 1, ApoA-H, ApoM, FTL), cell proliferation (Syndecan-2, and Annexin A2), and signal transduction (LRRC28 and FMR1). Additionally, a glutathione-binding protein involved in the detoxification of methylglyoxal known as GLO1 and an enzyme which increases the formation of prostaglandin E(2) known as PLA2G10 were up-regulated in HCC. Among the under-expressed genes discovered in HCC, most were responsible for liver-synthesized proteins (fibrinogen, complement species, amyloid, albumin, haptoglobin, hemopexin and orosomucoid).